Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous metoprolol tartrate for septic shock due to ventilator-associated pneumonia
PACTR202404531355476Phase 2Completed
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metoprolol in septic shock and ventilator-associated pneumonia (VAP) (2 arms). Primary endpoint: 28-day mortality. Started Oct 2023; status: completed.
02
Drugs
metoprolol
03
Conditions
septic shockventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on PACTR202404531355476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202404531355476.